Skip to Content

ROCHE 0245 ROCHE 0245 (Invirase 200 mg)

Generic Name: saquinavir

Pill with imprint ROCHE 0245 ROCHE 0245 is Green / Yellow, Capsule-shape and has been identified as Invirase 200 mg. It is supplied by Roche Laboratories.

Invirase is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Invirase 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ROCHE 0245 ROCHE 0245

Invirase 200 mg ROCHE 0245 ROCHE 0245
Invirase 200 mg ROCHE 0245 ROCHE 0245
Invirase 200 mg ROCHE 0245 ROCHE 0245

Invirase

Generic Name
saquinavir
Imprint
ROCHE 0245 ROCHE 0245
Strength
200 mg
Color
Green / Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roche Laboratories
Inactive Ingredients
lactose anhydrous, microcrystalline cellulose, povidone k30, sodium starch glycolate type A potato, magnesium silicate, magnesium stearate, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, FD&C Blue No. 2, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00004-0245 Roche
54868-3699 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.